Protagenic Therapeutics, Inc.\new
PTIX· OTC
PTIXProtagenic Therapeutics, Inc.\new
Filed Nov 14, 2011 · 10-Q · 45 days after period end · 0001144204-11-064110
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $12.33M | $9.18M |
| Net Income | -$4.52M | -$3.64M |
| EPS Diluted | -$0.72 | -$0.70 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protagenic Therapeutics, Inc.\new · CIK 1022899 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 14, 2011 · 45 d after period end
